资讯

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Processa Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings ...
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on developing the next generation cancer therapies with improved efficacy and ...
Investing.com — Processa Pharmaceuticals Inc. (PCSA)股价已跌至52周低点,触及0.22美元。这一显著下跌反映了公司正经历艰难时期,该股票一年内下跌了85.8%。根据 InvestingPro 数据显示,公司市值已萎缩至仅124万美元,而技术指标表明该股票处于超卖区域。投资者目睹了公司市值在过去一年中的急剧下降,因为该股票在市场压力和行业特定逆风中 ...
However, local pharmacists said you should also keep a close eye on your medicine cabinets.That's as President Donald Trump said pharmaceuticals could be next on the tariff list. WDSU Reporter ...
“We’re going to tariff our pharmaceuticals,” he said during his speech. “And once we do that, they’re going to come rushing back into our country because we’re the big market.” Pharmaceuticals and ...
Donald Trump has announced a plan to impose a "major tariff" on Pharmaceuticals, adding that the companies will not go to China or anywhere else. "Something that we have to do we're gonna tariff our ...
Since 2020, U.S. imports of Chinese pharmaceuticals — defined by the U.S. tariff code to include packaged medicaments, vaccines, blood, organic cultures, bandages, and organs — have grown by ...
"We're going to tariff our pharmaceuticals and once we do that, they're gonna come rushing back into our country because we're the big market," Trump said. "The advantage we have over everybody is ...
President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..
Though pharmaceuticals have been exempt from the tariffs announced until now, leaders in the drug industry have been bracing for their turn. “I think it’s a pivot point in U.S. policy and it feels ...